Clinical Trial Update: FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients [Phase 1]

View source ↗

Summary

Pfizer's first-in-human Phase 1 study is evaluating the tolerability of PF-07832837 in healthy adults and in patients with atopic dermatitis; the trial is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• PF-07832837

Snippet

Sponsor: Pfizer | Conditions: Healthy Participants, Atopic Dermatitis | Phase 1 | Status: RECRUITING